We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current DARE market cap is 29.06M. The company's latest EPS is USD -3.4666 and P/E is -0.96.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1M | 1.81M | 9k | 23k | 41k |
| Operating Income | -8.4M | -5.17M | -6.02M | -7.36M | -4.69M |
| Net Income | -8.3M | -5.06M | -6.76M | 12.91M | -4.7M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 10M | 2.81M |
| Operating Income | -14.34M | -27.4M | -39.07M | -31.39M | -30.94M |
| Net Income | -15.05M | -27.4M | -38.7M | -30.95M | -30.16M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.05M | 21.28M | 13.01M | 23.61M | 18.06M |
| Total Liabilities | 27.34M | 26.33M | 24.01M | 20.94M | 19.54M |
| Total Equity | -2.29M | -5.05M | -11M | 2.67M | -1.48M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.44M | 7.55M | 55.81M | 43.83M | 21.28M |
| Total Liabilities | 7M | 8.7M | 17.05M | 32.71M | 26.33M |
| Total Equity | 441k | -1.15M | 38.75M | 11.11M | -5.05M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.68M | -38.86M | -6.81M | 6.09M | 168k |
| Investing | -22k | -629k | -7k | -293k | -10k |
| Financing | 10.33M | 15.64M | 14k | 129k | 566k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.32M | -25.24M | -28.76M | -18.09M | -38.86M |
| Investing | 6.14M | -18k | -15k | -63k | -629k |
| Financing | 5.15M | 25.13M | 75.85M | 1.34M | 15.64M |
| Market Cap | 29.06M |
| Price to Earnings Ratio | -0.96 |
| Price to Sales Ratio | 10.32 |
| Price to Cash Ratio | 2.77 |
| Price to Book Ratio | -5.74 |
| Dividend Yield | - |
| Shares Outstanding | 8.7M |
| Average Volume (1 week) | 27.48k |
| Average Volume (1 Month) | 40.71k |
| 52 Week Change | -22.69% |
| 52 Week High | 7.56 |
| 52 Week Low | 2.6703 |
| Spread (Intraday) | 0.04 (1.19%) |
| Company Name | Dare Bioscience Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.darebioscience.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
